The Role of Antiplatelet Agents in the Management of Patients Receiving Intracardiac Closure Devices

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|12|10|1287-1291

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.12, Iss.10, 2006-04, pp. : 1287-1291

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antiplatelet Treatment in Peripheral Arterial Disease: The Role of Novel Antiplatelet Agents

By  

Current Pharmaceutical Design, Vol. 22, Iss. 29, 2016-09 ,pp. : 4610-4616

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Oral Antiplatelet Agents in Atherothrombotic Disease

By Ferguson James J.  

American Journal of Cardiovascular Drugs, Vol. 6, Iss. 3, 2006-01 ,pp. : 149-157

Adis International

Access to resources Recommend Favorite

Management of Preterm Infants with Intracardiac Thrombi: Use of Thrombolytic Agents

By Rimensberger P.C.   Humbert J.R.   Beghetti M.  

Pediatric Drugs, Vol. 3, Iss. 12, 2001-01 ,pp. : 883-898

Adis International

Access to resources Recommend Favorite

The role of antiplatelet therapy in the management of acute coronary syndromes

By Volturo Gregory A   Mazzola Jennifer L   Przylenk Karin  

Expert Opinion on Drug Safety, Vol. 4, Iss. 3, 2005-05 ,pp. : 541-556

Informa Healthcare

Access to resources Recommend Favorite

Oral Antiplatelet and Anticoagulant Agents in the Prevention and Management of Ischemic Stroke

By  

Current Pharmaceutical Design, Vol. 23, Iss. 9, 2017-04 ,pp. : 1377-1391

Bentham Science Publishers

Access to resources Recommend Favorite